CR
Cédric Rossi
CHU Dijon Bourgogne, Stanford University, Institut Universitaire du Cancer Toulouse Oncopole, Hospices Civils de Lyon
Research areas: Medicine · Pathology and Forensic Medicine · Lymphoma Diagnosis and Treatment · Chronic Lymphocytic Leukemia Research · Viral-associated cancers and disorders
0000-0003-3717-7961
Employment
- 2017 - Present
Education
-
Stanford University School of Medicine Post doctoral2021 - Present
-
Institut Universitaire du Cancer Toulouse Oncopole PhD2015 - 2018
-
Hospices Civils de Lyon Residency2012 - 2013
-
CHU Dijon-Bourgogne Residency2010 - 2015
-
Correspondances oNco-hématologie Editorial board
Projects & Funding
Projects & funding information is unavailable.
Publications (60)
- High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma Save
- Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling Save
- Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine Save
- Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial. Save
- Factors Affecting Health-Related Quality of Life among Survivors of Non-Hodgkin Lymphoma: A Population-Based Study Save
- [Frontline therapy for classical Hodgkin lymphoma patients]. Save
- Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab. Save
- Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma. Save
- Extranodal classical Hodgkin lymphoma involving the spinal cord: case report and review of the literature Save
- High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: TMTV is a useful risk factor to stratify patients at baseline Save
- Clinical and Economic Impact of a Multidisciplinary Follow-Up Program in Lymphoma Patients Save
- Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Major FDG-Avid Lymphomas Save
- Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study. Save
- Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma. Save
- COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). Save
- Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study. Save
- PD-1 inhibitors in patients with Hodgkin lymphoma. Save
- Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified. Save
- BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia. Save
- Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy. Save